Cargando…
Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 as Determinants of Sensitivity toward Anti-CD20 Monoclonal Antibody Therapy
Monoclonal antibody (mAb) therapy directed against CD20 is an important tool in the treatment of B cell disorders. However, variable patient response and acquired resistance remain important clinical challenges. To identify genetic factors that may influence sensitivity to treatment, the cytotoxic a...
Autores principales: | Small, George W., Akhtari, Farida S., Green, Adrian J., Havener, Tammy M., Sikes, Michael, Quintanhila, Julia, Gonzalez, Ricardo D., Reif, David M., Motsinger-Reif, Alison A., McLeod, Howard L., Wiltshire, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297299/ https://www.ncbi.nlm.nih.gov/pubmed/37371044 http://dx.doi.org/10.3390/cells12121574 |
Ejemplares similares
-
A Comparison of Association Methods for Cytotoxicity Mapping in Pharmacogenomics
por: Brown, Chad, et al.
Publicado: (2011) -
High-throughput screening and genome-wide analyses of 44 anticancer drugs in the 1000 Genomes cell lines reveals an association of the NQO1 gene with the response of multiple anticancer drugs
por: Akhtari, Farida S., et al.
Publicado: (2021) -
The influence of Neanderthal alleles on cytotoxic response
por: Akhtari, Farida S., et al.
Publicado: (2018) -
MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients
por: Gonzalez, Ricardo D., et al.
Publicado: (2023) -
RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients
por: Gonzalez, Ricardo D., et al.
Publicado: (2023)